First commercial batch of Covaxin released from Bharat Biotech’s new plant in Gujarat

By: |
August 29, 2021 12:36 PM

The government had earlier this month given approval to Bharat Biotech's Ankleshwar-based manufacturing plant to produce anti-COVID-19 vaccine Covaxin.

In May, Bharat Biotech announced that it planned to produce an additional 200 million doses of Covaxin

The first commercial batch of Covaxin was released on Sunday from the new plant of Bharat Biotech at Ankleshwar in Gujarat’s Bharuch district by Union Health Minister Mansukh Mandaviya.

“Vaccination is the most important thing to strengthen the country’s fight against coronavirus. Released the first commercial batch of #COVAXIN from Bharat Biotech’s plant at Ankleshwar, Gujarat today. This will increase the supply of vaccine in the country and will help the vaccine reach every Indian,” Mandaviya tweeted soon after the event.

The government had earlier this month given approval to Bharat Biotech’s Ankleshwar-based manufacturing plant to produce anti-COVID-19 vaccine Covaxin.

In May, Bharat Biotech announced that it planned to produce an additional 200 million doses of Covaxin at its subsidiary’s Ankleshwar-based facility. The Hyderabad-based firm had noted that it would utilise the manufacturing plant of its wholly-owned unit, Chiron Behring, to add another 200 million doses of Covaxin.

India administered 63.09 crore doses of COVID-19 vaccination in a nationwide drive till Sunday morning, as per the data released by the Union Health Ministry

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1This World Patient Safety Day, let’s work together to empower our nurses and midwives
2Covid-19: Researchers working on making edible plants like spinach, lettuce as mRNA vaccines; check details
3US OKs new use for Eli Lilly’s COVID-19 treatment